<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05796622</url>
  </required_header>
  <id_info>
    <org_study_id>MSS349R</org_study_id>
    <nct_id>NCT05796622</nct_id>
  </id_info>
  <brief_title>Evaluating an Innovative HIV Self-testing Service With Counseling Provided by a Chatbot</brief_title>
  <official_title>A Randomized Controlled Trial Evaluating an Innovative HIV Self-testing Service With Online Real-time Instruction, Pre-test and Post-test Counselling Provided by a Fully-automated Artificial Intelligence Chatbot (HIVST-Chatbot)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese University of Hong Kong</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese University of Hong Kong</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A parallel-group non-inferiority randomized controlled trial will then be conducted to&#xD;
      evaluate the performance of HIVST-Chatbot. A total of 528 Hong Kong Chinese speaking men who&#xD;
      have sex with men (MSM) aged â‰¥18 years who have access to live-chat applications are&#xD;
      recruited from multiple sources. Those who are diagnosed as HIV positive are excluded.&#xD;
      Participants are 1:1 randomized into the intervention group (n=264) or the control group&#xD;
      (n=264). The research team will implement the HIVST-Chatbot (HIVST services with real-time&#xD;
      counselling provided by a fully-automated artificial intelligence Chatbot) in the&#xD;
      intervention group and HIVST-OIC (HIVST with real-time counselling provided by trained&#xD;
      administrators) in the control group. Participants completed two telephone surveys at&#xD;
      baseline and six months afterwards.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 16, 2023</start_date>
  <completion_date type="Anticipated">February 28, 2024</completion_date>
  <primary_completion_date type="Anticipated">February 28, 2024</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Uptake of HIV self-testing</measure>
    <time_frame>6 months</time_frame>
    <description>Proportion of participants who use HIV self-testing during the 6-month follow-up period</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Proportion of HIV self-testing users receiving counselling along with testing</measure>
    <time_frame>6 months</time_frame>
    <description>Proportion of HIV self-testing users receiving counselling along with testing during the 6-month follow-up period</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">564</enrollment>
  <condition>Behaviors, Health</condition>
  <arm_group>
    <arm_group_label>HIVST-Chatbot (HIV self-testing services with counseling provided by a Chatbot)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Promote and implement HIV self-testing (HIVST) services with real-time counselling provided by a fully-automated artificial intelligence Chatbot (HIVST-Chatbot)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIVST-OIC (HIV self-testing services with counseling provided by administrators)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Promote and implement HIV self-testing (HIVST) services with real-time counselling provided by trained administrators)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HIVST-Chatbot (HIV self-testing services with counseling provided by a Chatbot)</intervention_name>
    <description>Promote and implement HIVST-Chatbot</description>
    <arm_group_label>HIVST-Chatbot (HIV self-testing services with counseling provided by a Chatbot)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>HIVST-OIC (HIV self-testing services with counseling provided by administrators)</intervention_name>
    <description>Promote and implement HIVST-OIC</description>
    <arm_group_label>HIVST-OIC (HIV self-testing services with counseling provided by administrators)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Hong Kong Chinese-speaking men aged at least 18 years old&#xD;
&#xD;
          -  Having had anal intercourse with at least one man in the past six months&#xD;
&#xD;
          -  Willing to leave contact information and be followed up at Month 6&#xD;
&#xD;
          -  Having access to the online live-chat application (WhatsApp)&#xD;
&#xD;
          -  Not intending to leave Hong Kong for one month consecutively within the next six&#xD;
             months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Self-reported as HIV positive&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Male at birth</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zixin Wang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chinese University of Hong Kong</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zixin Wang, PhD</last_name>
    <phone>+852 22528740</phone>
    <email>wangzx@cuhk.edu.hk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre for Health Behaviours Research, the Chinese University of Hong Kong</name>
      <address>
        <city>Hong Kong</city>
        <zip>666888</zip>
        <country>Hong Kong</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Hong Kong</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>March 20, 2023</study_first_submitted>
  <study_first_submitted_qc>March 31, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">April 3, 2023</study_first_posted>
  <last_update_submitted>March 31, 2023</last_update_submitted>
  <last_update_submitted_qc>March 31, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese University of Hong Kong</investigator_affiliation>
    <investigator_full_name>Zixin Wang</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

